Thomas BSc - Clovis Oncology Ex Officer
| CLVSDelisted Stock | USD 0.09 0.02 24.00% |
Insider
Thomas BSc is Ex Officer of Clovis Oncology
| Age | 49 |
| Phone | 303 625 5000 |
| Web | https://www.clovisoncology.com |
Clovis Oncology Management Efficiency
The company has return on total asset (ROA) of (0.3018) % which means that it has lost $0.3018 on every $100 spent on assets. This is way below average. Clovis Oncology's management efficiency ratios could be used to measure how well Clovis Oncology manages its routine affairs as well as how well it operates its assets and liabilities.The company currently holds 436.77 M in liabilities with Debt to Equity (D/E) ratio of 810.0, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Clovis Oncology has a current ratio of 1.15, suggesting that it is in a questionable position to pay out its financial obligations when due. Debt can assist Clovis Oncology until it has trouble settling it off, either with new capital or with free cash flow. So, Clovis Oncology's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Clovis Oncology sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Clovis to invest in growth at high rates of return. When we think about Clovis Oncology's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Murali Kuppuswamy | Hertz Global Holdings | 57 | |
| Harry Husted | BorgWarner | N/A | |
| Alan Prescott | Tesla Inc | 45 | |
| Kymber Lowe | Mondee Holdings | N/A | |
| Paul Stone | Hertz Global Holdings | 54 | |
| Jodi Allen | Hertz Global Holdings | 53 | |
| Donald Wright | American Axle Manufacturing | N/A | |
| Martin Viecha | Tesla Inc | N/A | |
| Venkat Pasupuleti | Mondee Holdings | 60 | |
| Stephen Scherr | Hertz Global Holdings | 59 | |
| Yuvraj Datta | Mondee Holdings | 53 | |
| Susan Donofrio | Mesa Air Group | N/A | |
| Kenny Cheung | Hertz Global Holdings | 42 | |
| Dolf Berle | Lindblad Expeditions Holdings | 60 | |
| Dave Arnold | Tesla Inc | N/A | |
| Angela Brav | Hertz Global Holdings | 57 | |
| Bradford Rich | Mesa Air Group | 62 | |
| Franz Holzhausen | Tesla Inc | N/A | |
| Michalis Tsakos | Mondee Holdings | N/A | |
| Dean Sinerius | Mesa Air Group | N/A | |
| David Lim | American Axle Manufacturing | N/A | |
Management Performance
| Return On Asset | -0.3 |
Clovis Oncology Leadership Team
Elected by the shareholders, the Clovis Oncology's board of directors comprises two types of representatives: Clovis Oncology inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Clovis. The board's role is to monitor Clovis Oncology's management team and ensure that shareholders' interests are well served. Clovis Oncology's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Clovis Oncology's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Anna Sussman, VP Relations | ||
| Thorlef Spickschen, Independent Director | ||
| BSc BSc, Exec Officer | ||
| Brian Atwood, Independent Director | ||
| Paul Klingenstein, Independent Director | ||
| Paul Gross, Executive Vice President Chief Compliance Officer, General Counsel | ||
| Robert Azelby, Director | ||
| Dale Hooks, Senior Vice President Chief Commercial Officer | ||
| Thomas BSc, Ex Officer | ||
| Patrick MA, CEO, CoFounder | ||
| Breanna Burkart, Sr. Director of Investor Relations | ||
| Patrick Mahaffy, President CEO, Director | ||
| Gillian IversRead, Executive Vice President - Technical Operations, Chief Regulatory Officer | ||
| Michael Barrett, Independent Chairman of the Board | ||
| James Blair, Independent Director | ||
| James Barrett, Independent Chairman of the Board | ||
| Richard Fair, Director | ||
| Edward McKinley, Independent Director | ||
| MB BSc, Chief Medical Officer and Executive VP of Clinical and Preclinical Devel. and Pharmacovigilance | ||
| Keith Flaherty, Director | ||
| Lindsey Rolfe, Chief Medical Officer, Executive Vice President - Clinical and Preclinical Development & Pharmacovigilance | ||
| Steven Hoerter, Chief Commercial Officer and Executive VP | ||
| Erle Mast, Co-Founder, CFO, Executive VP and Secretary | ||
| Ginger Graham, Independent Director | ||
| Ann Bozeman, Executive Vice President of Human Resources | ||
| Daniel Muehl, Principal Financial Officer, Principal Accounting Officer |
Clovis Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Clovis Oncology a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | -0.3 | |||
| Profit Margin | (1.89) % | |||
| Operating Margin | (1.55) % | |||
| Current Valuation | 651.32 M | |||
| Shares Outstanding | 144.96 M | |||
| Shares Owned By Insiders | 1.43 % | |||
| Shares Owned By Institutions | 25.89 % | |||
| Number Of Shares Shorted | 28.49 M | |||
| Price To Earning | (8.65) X | |||
| Price To Sales | 0.11 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Clovis Oncology in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Clovis Oncology's short interest history, or implied volatility extrapolated from Clovis Oncology options trading.
Pair Trading with Clovis Oncology
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Clovis Oncology position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Clovis Oncology will appreciate offsetting losses from the drop in the long position's value.Moving against Clovis Stock
| 0.77 | DIS | Walt Disney Sell-off Trend | PairCorr |
| 0.76 | AXP | American Express Financial Report 19th of July 2024 | PairCorr |
| 0.73 | DD | Dupont De Nemours Report 7th of May 2024 | PairCorr |
| 0.67 | GE | GE Aerospace Financial Report 23rd of July 2024 | PairCorr |
| 0.62 | CAT | Caterpillar Financial Report 6th of August 2024 | PairCorr |
The ability to find closely correlated positions to Clovis Oncology could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Clovis Oncology when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Clovis Oncology - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Clovis Oncology to buy it.
The correlation of Clovis Oncology is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Clovis Oncology moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Clovis Oncology moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Clovis Oncology can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Consideration for investing in Clovis Stock
If you are still planning to invest in Clovis Oncology check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Clovis Oncology's history and understand the potential risks before investing.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |